- Home
- CRMD vs LXRX Comparison
CRMD vs LXRX Comparison
Compare CRMD & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMD | LXRX |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | United States |
| Employees | 191 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 703.3M |
| IPO Year | 2009 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CRMD | LXRX |
|---|---|---|
| Price | $8.77 | $2.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $14.83 | $4.15 |
| AVG Volume (30 Days) | 1.5M | ★ 4.2M |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | 77.78 |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $311,709,000.00 | $49,803,000.00 |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.44 | ★ N/A |
| Revenue Growth | ★ 617.03 | 60.24 |
| 52 Week Low | $6.13 | $1.00 |
| 52 Week High | $14.96 | $2.68 |
Technical Indicators
Market Signals| Indicator | CRMD | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 60.57 |
| Support Level | $8.09 | $1.17 |
| Resistance Level | $9.03 | $2.53 |
| Average True Range (ATR) | 0.39 | 0.16 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 84.34 | 61.18 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.